7-81963904-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_000722.4(CACNA2D1):c.2780+152A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.218 in 669,750 control chromosomes in the GnomAD database, including 16,559 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.23 ( 4146 hom., cov: 32)
Exomes 𝑓: 0.22 ( 12413 hom. )
Consequence
CACNA2D1
NM_000722.4 intron
NM_000722.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0690
Publications
1 publications found
Genes affected
CACNA2D1 (HGNC:1399): (calcium voltage-gated channel auxiliary subunit alpha2delta 1) The preproprotein encoded by this gene is cleaved into multiple chains that comprise the alpha-2 and delta subunits of the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. Mutations in this gene can cause cardiac deficiencies, including Brugada syndrome and short QT syndrome. Alternate splicing results in multiple transcript variants, some of which may lack the delta subunit portion. [provided by RefSeq, Nov 2014]
CACNA2D1 Gene-Disease associations (from GenCC):
- short QT syndromeInheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: ClinGen, Orphanet
- Brugada syndromeInheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- developmental and epileptic encephalopathy 110Inheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
- Brugada syndrome 1Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 7-81963904-T-C is Benign according to our data. Variant chr7-81963904-T-C is described in ClinVar as Benign. ClinVar VariationId is 1226323.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.274 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.229 AC: 34763AN: 151814Hom.: 4139 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
34763
AN:
151814
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.215 AC: 111498AN: 517818Hom.: 12413 AF XY: 0.214 AC XY: 59355AN XY: 277172 show subpopulations
GnomAD4 exome
AF:
AC:
111498
AN:
517818
Hom.:
AF XY:
AC XY:
59355
AN XY:
277172
show subpopulations
African (AFR)
AF:
AC:
3811
AN:
13376
American (AMR)
AF:
AC:
4970
AN:
24394
Ashkenazi Jewish (ASJ)
AF:
AC:
3002
AN:
15876
East Asian (EAS)
AF:
AC:
7540
AN:
31282
South Asian (SAS)
AF:
AC:
10901
AN:
50470
European-Finnish (FIN)
AF:
AC:
8818
AN:
44084
Middle Eastern (MID)
AF:
AC:
467
AN:
2092
European-Non Finnish (NFE)
AF:
AC:
65954
AN:
308304
Other (OTH)
AF:
AC:
6035
AN:
27940
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
4490
8980
13471
17961
22451
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
586
1172
1758
2344
2930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.229 AC: 34799AN: 151932Hom.: 4146 Cov.: 32 AF XY: 0.228 AC XY: 16959AN XY: 74246 show subpopulations
GnomAD4 genome
AF:
AC:
34799
AN:
151932
Hom.:
Cov.:
32
AF XY:
AC XY:
16959
AN XY:
74246
show subpopulations
African (AFR)
AF:
AC:
11543
AN:
41454
American (AMR)
AF:
AC:
3287
AN:
15218
Ashkenazi Jewish (ASJ)
AF:
AC:
676
AN:
3462
East Asian (EAS)
AF:
AC:
1000
AN:
5146
South Asian (SAS)
AF:
AC:
1147
AN:
4826
European-Finnish (FIN)
AF:
AC:
2177
AN:
10596
Middle Eastern (MID)
AF:
AC:
83
AN:
294
European-Non Finnish (NFE)
AF:
AC:
14216
AN:
67910
Other (OTH)
AF:
AC:
510
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1354
2708
4063
5417
6771
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
368
736
1104
1472
1840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
718
AN:
3472
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jun 25, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.